1. Almeida KJ, deMacedo LP, Lemos de Melo Lobo Jofili Lopes J, et al. Modified Pfeffer Questionnnaire for Functional Assessment in Parkinson Disease. J Geriatr Psychiatry Neurol. January 2017; Epub ahead of print.
2. Koprich JB, Kalia LV, Brotchie JM. Animal models of a-synucleinopathy for Parkinson disease drug development. Nat Rev Neurosci. July 2017; Epub ahead of print.
3. Park J, LeeJW, Cooper SC, et al. Parkinson disease-associated LRRK2 G2019S transgene disrupts marrow myelopoisesis and peripheral Th17 response. J Leukoc Biol. July 2017; Epub ahead of print.
4. West AB. Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease. Exp Neurol. July 2017; Epub ahead of print.